DOI: 10.1186/s41181-017-0034-8Pages: 1-6

Generation of fluorescently labeled tracers – which features influence the translational potential?

1. Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center

2. University of Oxford, Department of Oncology, CRUK&MRC Oxford Institute for Radiation Oncology

3. University Hospital Basel, Department of Nuclear Medicine

4. Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV – IRCCS

5. Université d’Angers, Université de Nantes, CRCINA, INSERM, CNRS

6. University Federico II, Department of Advanced Biomedical Sciences

7. In vivo Cellular and Molecular Imaging Lab (ICMI)-Department, Vrije Universiteit Brussel

8. Department of Radiology & Nuclear Medicine, Erasmus Medical Centre

Correspondence to:
Fijs W. B. van Leeuwen



Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses the does and don’ts in developing fluorescence tracers. It has been put forward by the European Association of Nuclear Medicine (EANM) Translational Molecular Imaging & Therapy committee and has been approved by the EANM board.

This article is freely available, click here to access the full text/PDF

  • Accepted: Nov 23, 2017
  • Online: Dec 15, 2017

Article Tools